c="glycine-586" 1:8 1:8||t="medication"||cui="C0017890"||tot="Glycine"||ns="-861"
c="osteogenesis imperfecta type IV" 1:13 1:16||t="problem"||cui="C0268363"||tot="Osteogenesis imperfecta type IV"||ns="-1000"
c="control cDNA probes" 2:15 2:17||t="treatment"||cui="C0182400"||tot="Probes"||ns="-827"
c="osteogenesis imperfecta type IV" 2:31 2:34||t="problem"||cui="C0268363"||tot="Osteogenesis imperfecta type IV"||ns="-1000"
c="polymerase chain reaction" 2:55 2:57||t="test"||cui="C0032520"||tot="Polymerase Chain Reaction"||ns="-1000"
c="glycine" 2:82 2:82||t="medication"||cui="C0017890"||tot="Glycine"||ns="-1000"
c="valine" 2:84 2:84||t="medication"||cui="C0042285"||tot="Valine"||ns="-1000"
c="amino acid position 586" 2:86 2:89||t="medication"||cui="C0002520"||tot="Amino Acids"||ns="-861"
